The Research of Knowledge Level About Double or Triple Tests of Pregnant

Öz

Aim: Our aim in this study is measuring the knowledge levels of pregnant about double or triple test.Materials and Methods: The study group consists of 11-20 weeks 222 pregnant who comes to Ahi Evran University Training and Research Hospital Obstetrical Poliyclinic between September 2014 and December 2014 for the routine controlling. The demographic information and the questions in a survey form to measure the knowledge level about double or triple test were asked to all pregnant women who were included in.Results: The answers to the question of where they learned the existence of double or triple tests DTT from were, my doctor recommended 192 %86.5 , learned from internet 18 %8.1 , my friends recommended 6 %2.7 , learned from TV or newspapers 6 %2.7 . The answers to the question of what the purpose of DTT is, to determine the intelligence level of baby 46 %20.8 , to determine the risk of baby’s physical disability 88 %39.6 , to determine the Down syndrome and other chromosomal abnormalities 72 %32.4 , I don’t know 16 %17.2 . The answers to the question of DTT are mandatory to be done were, yes 176 %79.3 , no 46 %20.7 . The answers to the question of the meaning of high-risk DTT results is, your baby is certainly disabled were, yes 98 %44.1 , no 124 %55.9 . The answers were to the question of the meaning of no high-risk results is, your baby is completely healthy, yes 62 %27.9 , no 160 %72.1 . The answers were to the question of do you believe in DTT are reliable tests, yes 156 %70.3 , no 66 %29.7 . The answers to the question of do you need to remake DTT in other medical center when DTT results are high-risky were, yes 172 %32.4 , no 150 %67.6 . The answers to the question of what should be done when DTT results are high risky were, baby should have aborted 32 %14.4 , amniocentesis should be done 152 %68.5 , nothing should be done and wait for the birth 38 %17.1 . The answers to the question of do you want to give birth to your child when it has appeared after the invasive analysis that your baby is disabled were, yes 126 %56.8 , no 96 %43.2 .Results: As a result the prenatal tests which applied for determining the fetal anomalies are important for both pregnant and the doctor. The medical personnel should give stimulating information to pregnant about these tests, it should be targeted to prevent existing worries and confusing but the final decision should be left to pregnant. A national policy should be established in the procedure of prenatal screening and proper conditions should be composed at the healthcare centers for this policy to be useful and effective.

Anahtar Kelimeler

• Double test,triple test,the knowledge level of pregnant

Gebelerin İkili ya da Üçlü Testler Hakkındaki Bilgi Düzeyinin Araştırılması

Öz

Amaç: Çalışmadaki amacımız gebelerin ikili yada üçlü test hakkındaki bilgi düzeylerini ölçmektir.Gereç ve Yöntemler: Çalışma grubunu Kırşehir Ahi Evran Üniversitesi Eğitim ve Araştırma Hastanesi doğum polikliniğine 2014 yılında Eylül-Aralık ayları arasında rutin takiplerini yaptırmak amaçlı gelen 11- 20 haftalık 222 gebe oluşmuştur. Çalışmaya dahil edilen tüm gebelere demografik bilgilerini ve ikili yada üçlü taramalar hakkında bilgi düzeylerini ölçmek amaçlı anket şeklinde sorular sorulmuştur.Bulgular: İkili ya da üçlü tarama testinin İÜTT varlığını nereden öğrendikleriniz sorusuna verilen cevaplar, doktorum tavsiye etti 192 %86,5 , internetten öğrendim 18 %8,1 , arkadaşlarım tavsiye etti 6 %2,7 , tv ya da gazeteden öğrendim 6 %2.7 şeklindeydi. İÜTT ne amaçlı yapılır sorusuna verilen cevaplar, bebeğin zeka seviyesini belirleme amaçlı 46 %20,8 , bebeğin fiziksel sakatlık riskini saptamak amaçlı 88 %39,6 , Down sendromu ve diğer kromozomal anomalileri saptamak amaçlı 72 %32,4 , bilmiyorum 16 %7.2 şeklindeydi. İÜTT yaptırılması zorunlu mudur sorusuna verilen cevaplar evet 176 %79,3 , hayır 46 %20,7 şeklindeydi. İÜTT ‘nin yüksek riskli çıkması bebeğinizin kesin özürlü olduğu anlamına gelir mi sorusuna verilen cevaplar evet 98 %44,1 , hayır 124 %55,9 şeklinde idi.İÜTT’nin yüksek riskli çıkmaması bebeğinizin tamamen sağlıklı olduğu anlamına gelir mi soruna verilen cevaplar evet 62 %27,9 hayır 160 %72,1 şeklinde idi. İÜTT’nin güvenli testler olduğuna inanıyor musunuz soruna verilen cevaplar evet 156 %70,3 hayır %66,7 şeklinde idi. İÜTT’nin yüksek riskli çıkması sonucunda testleri başka merkezde tekrarlama ihtiyacı duyar mısınız sorusuna verilen cevaplar evet 72 %32,4 hayır 150 %67,6 şeklinde idi. İÜTT sonuçlarının yüksek risk içermesi sonucunda ne yapılır sorusuna verilen cevaplar bebek kürtaj yoluyla alınır 32 %14,4 , amniosentez yapılır 152 %68,5 , hiçbirşey yapılmaz ve doğum beklenir 38 %17,1 . Yapılan invaziv tahliller sonucunda bebeğinizin özürlü olduğu anlaşırsa bebeğinizi doğurmak ister misiniz sorusuna verilen cevaplar evet 126 %56,8 hayır 96 %43,2 şeklinde idi.Sonuç: Sonuç olarak fetal anomalileri saptayabilmek için uygulanan prenatal testler hem gebe hem de hekim için önemlidir. Bu testler hakkında sağlık personeli gebeye aydınlatıcı bilgiler vermeli, mevcut kaygıların ve kafa karışıklığın önüne geçmesi hedeflenmeli ancak nihai karar gebelere bırakılmalıdır. Prenatal tarama prosedürlerinde ulusal bir politika oluşturulmalı ve sağlık merkezlerinde bu politikaların yararlı ve etkili olabilmesi için uygun koşullar sağlanmalıdır.

Anahtar Kelimeler

• İkili tarama,üçlü tarama,gebe bilgi düzeyi

Kaynakça

1. Diribaş K, Kaya C, Koç Fa. İlk Trimester Fetal Tarama Testleri. Türkiye Klinikleri Jinekoloji Obstetrik Dergisi 2002;12:186-191.
2. Nıcolaıdes Kh, Heath V, Cıcero S. Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn, 2002;22:308.
3. Cıcero S, Bındra R, Rembouskos G, Spencer K, Nıcolaıdes Kh, Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translu-cency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003;23:306.
4. Spencer K, Nıcolaıdes Kh. Screening for trisomy 21 in twins using first tri- mester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Br J Obstet Gynaecol 2003;110:281.
5. Pajtler M, Audy-Jurković S, Kardum-Skelin I, Ma-hovlić V, Mozetic-Vr- doljak D, Ovanin-Rakić A.Organisation of cervical cytology screening in Croa-tia: past, present and future. Coll Antropol. 2007;2:47-54
6. Kornman LH, Wortelboer Mjm, BeekhuısJ r, Mors-sınk LP, Mantıngh A. Women’s opinions and the implications of first- versus second-trimester screening for fetal Down’s syndrome. Prenat Diagn 1997;17:1011.
7. Michie S, Smith D, Marteau TM. Prenatal tests: how are women deci- ding? Prenat Diagn. 1999;19:743-8.
8. Spencer K, Aitken D, Factors affecting women’s preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol. 2004;24:735-9.

9. Al-Jader Ln, Parry-Langdon N, William Smith Rj. Survey Of Attitudes Of Pregnant Women Towards-Down Syndrome Screening. Prenat Diagn. 2000;20:23–29.
10. Kyle D, Cummins C, Evans S. Factors Affecting The Uptake Of Screening For Neural Tube Defect. Br J Obstet Gynaecol. 1988;95:560–564.
11. Marteau Tm, Johnson M, Kidd J, Michie S, Cook R. Psychological Models İn Predicting Uptake Of Prenatal Screening. Psychol Health. 1992;6:13-22.
12. Drake Er, Engler-Todd L, O’connor Am, Surh Lc, Hunter A. Development And Evaluation Of A Decision Aid About Prenatal Testing For Women Of Advanced Maternal Age. J Genetic Counseling.1999;8:217–233.
13. Santalahti P, Hemminki E, Latikka AM, Ryynanen. M. Women’s Decisi- on-Making İn Prenatal Screening. Soc Sci Med. 1998;46:1067–1076.
14. Baillie C, Smith J, Hewison J, Mason G. Ultrasound Screening For Chro- mosomal Abnormality: Women’s Reactions To False Positive Results. Br J Health Psychol. 2000;5:377–394.
15. Searle J. Fearing The Worst–Why Do Pregnant Women Feel ‘At Risk’? Aust Nz J Obstet Gynaecol.1996;36:279– 286.
16. Omar Ma, Schiffman Rf, Bauer P. Recipient And Provider Perspectives Of Barriers To Rural Prenatal Care. J Community Health Nurs 1998;15:237– 249.
17. Spencer K, Aitken D, Spencer K, Aıtken D, Factors affecting women’s preference for type of prenatal screening test for chromosomal anoma- lies.. Ultrasound Obstet Gynecol. 2004;24:735-9
18. Mulvey S, Wallace Em, Women’s knowledge of and attitudes to first and second trimester screening for Down’s syndrome. Br J Obstet Gynaecol 2000;107:1302.
19. De Graaf I, Tıjmstra T, Bleker Op, Van Lıth Jmm, Womens’ preference in Down syndrome screening. Prenat Diagn 2002;22:624.
20. Weınans Mjn, Huıjssoon Amg, Tymstra T, Gerrıts Mcf, Beekhuıs Jr, Mantıngh A. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 2000;20:705.
21. Van den Berg M, Timmermans DR, Kleinveld JH, Garcia E, van Vugt JM, van der Wal G. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn 2005;25:84.
22. Press N, Browner Ch. Why Women Say Yes To Prenatal Diagnosis. Soc. Sci. Med 1997;45:979–989.
23. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. Informed Consent To Serum Screening For Down Syndrome: Are Women Given Adequate İnformation? Prenat Diagn. 1999;19:1–7.
24. Smith Dk, Slack J, Shaw Rw, Marteau Tm. Lack Of Knowledge İn Health Professionals: A BarrierTo Providing İnformation To Patients? Qual Health Care. 1994;3:75–78.
25. Statham H, Green J. Serum Screening For Down’s Syndrome: Some Wo- men’s Experiences. BMJ 1993;307:174–176.
26. Nıcolaıdes Kh, Chervenak Fa, Mccullough Lb, Avgıdou K, Papageorghıou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assess- ment of risk for trisomy 21. Am J Obstet Gynecol 2005;193:322.
27. Van den Berg M, Timmermans DR, Kleinveld JH, Garcia E, van Vugt JM, van der Wal G. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s rea-sons. Prenat Diagn 2005;25:84.
28. Paravic J, Brajenovic-Milic B, Tislaric D, Kapovic M, Botica A, Jurcan V, Milotti S. Maternal serum screening for Down syndrome: a survey of pregnant women’s views. Community Genet. 1999;2:109-12.
29. Seror V, Vılle Y. Prenatal screening for Down syndrome: women’s invol- vement in decision-making and their attitudes to screening. Prenat Diagn 2009;29:120.
30. Milicić-Juhas V, Perić M, Pajtler M, Prvulović I, Curzik D. Pap test-with or without vaginal smear? Coll Antropol 2010;34:69.
31. Dormandy E, Mıchıe S, Hooper R, Marteau Tm. Low uptake of prena- tal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women’s attitudes or a failure to facilitate informed choices? Int J Epidemiol 2005;34:346.
32. Jaques Am, Sheffıeld Lj, Hallıday Jl, Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome Prenat Diagn 2005;25:656.
33. Mıchıe S, Marteau Tm, Prenatal tests: how are women deciding? Prenat- Diagn 1999;19:743.
34. Dormandy E, Marteau Tm. Uptake of a prenatal screening test: the role of healthcare professionals’ attitudes towards the test. Prenat Diagn 2004;24:864.
35. Grant Ss. Options for Down syndrome screening: what will women cho- ose? J Midwifery Womens Health. 2005;50:211-8.
36. Katalinić S, Frković A, Dobi-Babić R. Role of physi-cians in violence aga- inst women in family. Lijec Vjesn. 2005;127:146-50.
37. Statham H, Green J. Serum Screening For Down’s Syndrome: Some Wo- men’s Experiences. BMJ 1993;307:174–176.
38. Ryder Ih. Prenatal Screening For Down Syndrome: A Dilemma For The Unsupported Midwife? Midwifery. 1999;15:16–23.
39. Smith Dk, Shaw Rw, Marteau Tm. Informed Consent To Undergo Serum Screening For Down’s Syndrome: The Gap Between Policy And Practice. BMJ 1994;309:776.
40. Stefansdottır V, Skırton H, Jonasson K, Hardardottır H, Jonsson J. Effects of knowledge, education, and experience on acceptance of first trimes- ter screening for chromosomal anomalies. Acta Obstet Gynecol Scand. 2010;89:931-8
41. Van Den Berg M, Tımmermans Drm, Kleınveld Jh, Garcıa E, Van Vugt Jmg, Van Der Val G. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn 2005;25:84.